
Organization
Organon scored poorly because it consistently prioritizes identity-based and activist-driven policies over merit and business focus, resulting in high risk ratings across advocacy, funding, political action, and employment categories. This pattern of embracing divisive social initiatives at the expense of shareholder and consumer interests drove its overall high-risk classification.
Free account · your comment posts right after signup
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.